SBC Medical Group Holdings Incorporated
SBCIndustrialsNASDAQConsulting Services
Scan Results
Daily timeframeSBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. Valued at $543.0M, SBC is a small-cap name in its sector. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement.
Market Cap
$543.0M
Beta
0.55
P/E (TTM)
11.23
P/E (Fwd)
9.78
EPS (TTM)
$0.47
EPS (Fwd)
$0.54
ROE
18.9%
ROA
11.3%
Cash
$184.6M
Total Debt
$48.2M
Free CF
$63.2M
52W Change
42.3%
Annual Financials
Cash vs Debt
Where SBC stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, SBC finished 43.32% above its 150-day moving average ($3.74) and 38.50% above its 200-day moving average ($3.87). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SBC overbought or oversold?
At the October 20, 2026 close, SBC's RSI(14) was 71.7, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $184.6M in cash and $48.2M in debt, SBC maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $63.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 18.9%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 11.3% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $174.2M (2022) to $173.6M (2025).
The relatively low beta of 0.55 suggests SBC is a less volatile holding compared to the broader index. With cash comfortably exceeding debt, SBC has financial flexibility that may help navigate uncertain periods. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence SBC Medical Group Holdings Incorporated's trajectory.